Recent meta-analyses show that low-dose lithium has comparable or even superior efficacy to modern anti-amyloid antibodies in Alzheimer's disease and mild cognitive impairment. Lithium has a multimodal neuroprotective effect, is well tolerated, inexpensive and could represent a promising option in Alzheimer's prevention and treatment.
Magnesium L-threonate is a special form of magnesium that can cross the blood-brain barrier much better than conventional magnesium compounds. This increases the magnesium level directly in the brain, which is crucial for memory, learning ability and neuronal regeneration. Studies suggest that this special magnesium compound can contribute to both the prevention and therapeutic support of dementia.
© Copyright by Deutsche Stiftung für Gesundheitsinformation und Prävention | All Rights Reserved
